Study S002009

A Long-term, Randomized, Open-labeled, Parallel-group Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT01593137
Acronym: ADELANTE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2012-05
Primary completion: 2013-12
Lead sponsor: Fundación Fernández-Cruz
Conditions: Type 2 Diabetes
Interventions: DRUG:Liraglutide + metformin; DRUG:Glimepiride + metformin
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2012-000311-87

Registered primary outcomes

assess the effect of treatment with liraglutide compared to glimepiride, as add-on to metformin, for one year on circulating levels of EPCs in patients with type 2 diabetes poorly controlled. [1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.